Pmv Pharmaceuticals Stock Buy Hold or Sell Recommendation
| PMVP Stock | USD 1.59 0.02 1.24% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Pmv Pharmaceuticals is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Pmv Pharmaceuticals given historical horizon and risk tolerance towards Pmv Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Pmv Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Pmv Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide. Note, we conduct extensive research on individual companies such as Pmv and provide practical buy, sell, or hold advice based on investors' constraints. Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Pmv |
Execute Pmv Pharmaceuticals Buy or Sell Advice
The Pmv recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pmv Pharmaceuticals. Macroaxis does not own or have any residual interests in Pmv Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pmv Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Pmv Pharmaceuticals Trading Alerts and Improvement Suggestions
| Pmv Pharmaceuticals may become a speculative penny stock | |
| Pmv Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (68.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pmv Pharmaceuticals currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Pmv Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: PMV Pharmaceuticals files 200M mixed securities shelf - TipRanks |
Pmv Pharmaceuticals Returns Distribution Density
The distribution of Pmv Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Pmv Pharmaceuticals' future price movements. The chart of the probability distribution of Pmv Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Pmv Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pmv Pharmaceuticals returns is essential to provide solid investment advice for Pmv Pharmaceuticals.
| Mean Return | 0.11 | Value At Risk | -3.64 | Potential Upside | 3.75 | Standard Deviation | 2.42 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pmv Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pmv Stock Institutional Investors
The Pmv Pharmaceuticals' institutional investors refer to entities that pool money to purchase Pmv Pharmaceuticals' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Goldman Sachs Group Inc | 2024-06-30 | 808.7 K | Millennium Management Llc | 2024-06-30 | 758.7 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 705.6 K | Personal Cfo Solutions, Llc | 2024-06-30 | 550.3 K | Citigroup Inc | 2024-09-30 | 514.9 K | Two Sigma Advisers, Llc | 2024-06-30 | 493.5 K | Two Sigma Investments Llc | 2024-09-30 | 483.1 K | Barclays Plc | 2024-06-30 | 465 K | Acuitas Investments, Llc | 2024-09-30 | 440.7 K | Orbimed Advisors, Llc | 2024-06-30 | 6.5 M | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 3.6 M |
Pmv Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 3.3M | 27.9M | (142.2M) | 6.6M | (24.7M) | (26.0M) | |
| Change In Cash | 43.0M | 288.1M | (188.1M) | (64.2M) | (70.6M) | (67.1M) | |
| Free Cash Flow | (22.2M) | (32.9M) | (47.9M) | (71.7M) | (56.6M) | (59.4M) | |
| Depreciation | 388K | 318K | 307K | 315K | 1.3M | 1.3M | |
| Other Non Cash Items | 8K | 143K | 955K | (385K) | (5.8M) | (5.5M) | |
| Capital Expenditures | 109K | 148K | 1.3M | 8.0M | 962K | 913.9K | |
| Net Income | (25.4M) | (34.4M) | (57.8M) | (73.3M) | (69.0M) | (72.4M) | |
| End Period Cash Flow | 73.3M | 361.4M | 173.3M | 109.1M | 38.5M | 36.6M | |
| Change To Netincome | 978K | 2.2M | 6.8M | 10.1M | 11.6M | 12.2M |
Pmv Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pmv Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pmv Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pmv stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.62 | |
σ | Overall volatility | 2.42 | |
Ir | Information ratio | -0.01 |
Pmv Pharmaceuticals Volatility Alert
Pmv Pharmaceuticals currently demonstrates below-average downside deviation. It has Information Ratio of -0.01 and Jensen Alpha of 0.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pmv Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pmv Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Pmv Pharmaceuticals Fundamentals Vs Peers
Comparing Pmv Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pmv Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Pmv Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pmv Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pmv Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Pmv Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pmv Pharmaceuticals to competition |
| Fundamentals | Pmv Pharmaceuticals | Peer Average |
| Return On Equity | -0.24 | -0.31 |
| Return On Asset | -0.2 | -0.14 |
| Current Valuation | (86.26 M) | 16.62 B |
| Shares Outstanding | 51.75 M | 571.82 M |
| Shares Owned By Insiders | 2.30 % | 10.09 % |
| Shares Owned By Institutions | 80.89 % | 39.21 % |
| Number Of Shares Shorted | 847.18 K | 4.71 M |
| Price To Book | 0.42 X | 9.51 X |
| EBITDA | (78.88 M) | 3.9 B |
| Net Income | (68.96 M) | 570.98 M |
| Cash And Equivalents | 277.43 M | 2.7 B |
| Cash Per Share | 6.08 X | 5.01 X |
| Total Debt | 13.29 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 24.76 X | 2.16 X |
| Book Value Per Share | 3.82 X | 1.93 K |
| Cash Flow From Operations | (55.66 M) | 971.22 M |
| Short Ratio | 4.16 X | 4.00 X |
| Earnings Per Share | (1.00) X | 3.12 X |
| Price To Earnings To Growth | (0.31) X | 4.89 X |
| Target Price | 5.8 | |
| Number Of Employees | 63 | 18.84 K |
| Beta | 1.48 | -0.15 |
| Market Capitalization | 83.31 M | 19.03 B |
| Total Asset | 252.15 M | 29.47 B |
| Retained Earnings | (310 M) | 9.33 B |
| Working Capital | 193.38 M | 1.48 B |
| Net Asset | 252.15 M |
Note: Disposition of 9000 shares by David Mack of Pmv Pharmaceuticals at 0.53 subject to Rule 16b-3 [view details]
Pmv Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pmv . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 17127.02 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.63 | |||
| Day Typical Price | 1.62 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 71.88 |
About Pmv Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Pmv Pharmaceuticals? Buying financial instruments such as Pmv Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Pmv Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Yield ETFs Thematic Idea Now
High Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 105 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.